Goldman Sachs’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.55M | Sell |
|
|||||
|
2025
Q1 | $3.51M | Sell |
|
|||||
|
2024
Q4 | $5.61M | Sell |
|
|||||
|
2024
Q3 | $9.32M | Buy |
|
|||||
|
2024
Q2 | $10.9M | Buy |
|
|||||
|
2024
Q1 | $9.77M | Sell |
|
|||||
|
2023
Q4 | $8.13M | Buy |
|
|||||
|
2023
Q3 | $6.67M | Sell |
|
|||||
|
2023
Q2 | $8.52M | Buy |
|
|||||
|
2023
Q1 | $5.96M | Buy |
|
|||||
|
2022
Q4 | $8.33M | Buy |
|
|||||
|
2022
Q3 | $6.55M | Sell |
|
|||||
|
2022
Q2 | $8.47M | Buy |
|
|||||
|
2022
Q1 | $5.89M | Buy |
|
|||||
|
2021
Q4 | $5.46M | Sell |
|
|||||
|
2021
Q3 | $4.73M | Buy |
|
|||||
|
2021
Q2 | $3.11M | Buy |
|
|||||
|
2021
Q1 | $2.27M | Buy |
|
|||||
|
2020
Q4 | $2.05M | Buy |
|
|||||
|
2020
Q3 | $652K | Buy |
|